Free Newsletter
HRT doesn't protect women from heart disease
Investigators have identified a molecule that counteracts estrogen in the cardiovascular system as well as activating estrogen receptors in breast tissue, promoting the development of tumors. The scientific team at the University of Texas Southwestern Medical Center in Dallas say that a drug that inhibits 27HC could play a big role in promoting women's health. Their work has helped explain why the Women's Health Initiative astounded many observers several years ago when it revealed that hormone replacement therapy was linked to a higher rate of heart disease. It turns out that 27HC is produced while the body processes cholesterol.
- see the release on the findings
- read the article from The Wall Street Journal (sub. req.)
ALSO: University of Iowa researchers have discovered a gene that plays a linchpin role in the ability of breast cancer cells to respond to estrogen. The finding may lead to improved therapies for hormone-responsive breast cancers and may explain differences in the effectiveness of current treatments. Release
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceBiotech Research email newsletter for FREE!
Be the first to comment